Does CANTHARIDIN Cause Application site vesicles? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Application site vesicles have been filed in association with CANTHARIDIN (YCANTH). This represents 43.9% of all adverse event reports for CANTHARIDIN.
50
Reports of Application site vesicles with CANTHARIDIN
43.9%
of all CANTHARIDIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Application site vesicles From CANTHARIDIN?
Of the 50 reports, 1 (2.0%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
Yes, Application site vesicles is listed as a known adverse reaction in the official FDA drug label for CANTHARIDIN.
What Other Side Effects Does CANTHARIDIN Cause?
Application site pain (35)
Blister (23)
Pain (10)
Off label use (6)
Product communication issue (6)
Accidental exposure to product (5)
Anogenital warts (5)
Skin plaque (5)
Vulvovaginal pain (5)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which CANTHARIDIN Alternatives Have Lower Application site vesicles Risk?
CANTHARIDIN vs CAPECITABINE
CANTHARIDIN vs CAPIVASERTIB
CANTHARIDIN vs CAPLACIZUMAB
CANTHARIDIN vs CAPLACIZUMAB-YHDP
CANTHARIDIN vs CAPMATINIB